Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study

Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study

BackgroundIn psoriatic arthritis (PsA), the primary goal of treatment is clinical remission. This study aimed to characterize the molecular profile underlying the induced clinical remission in patients with PsA, comparing the remission state and the healthy condition.MethodsWhole blood transcriptomi...

Full description

Bibliographic Details
Main Authors: Maria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, Mattia Congia, Elisabetta Chessa, Micaela Rita Naitza, Matteo Piga, Alberto Cauli
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
psoriatic arthritis
clinical remission
transcriptomic
FOS
CCDC50
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1274539/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1274539/full

Similar Items